Jim Ziegler
Corporate Officer/Principal chez IOVANCE BIOTHERAPEUTICS, INC.
Profil
Jim Ziegler is currently the Executive Vice President-Commercial at Iovance Biotherapeutics, Inc. He previously held positions as the Head-Sales & Marketing at Amgen, Inc., Gilead Sciences, Inc., Pfizer Inc., Biogen, Inc., and Nodality, Inc. He also served as the Vice President-Sales & Marketing at Nodality, Inc. and as a Principal in The United States Army (District of Columbia).
Mr. Ziegler holds an MBA from The University of Chicago and an undergraduate degree from the US Military Academy.
Postes actifs de Jim Ziegler
Sociétés | Poste | Début |
---|---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2020 |
Anciens postes connus de Jim Ziegler
Sociétés | Poste | Fin |
---|---|---|
The United States Army (District of Columbia) | Corporate Officer/Principal | - |
GILEAD SCIENCES, INC. | Sales & Marketing | - |
BIOGEN INC. | Sales & Marketing | - |
AMGEN INC. | Sales & Marketing | - |
PFIZER, INC. | Sales & Marketing | - |
Formation de Jim Ziegler
The University of Chicago | Masters Business Admin |
US Military Academy | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
AMGEN INC. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
PFIZER, INC. | Health Technology |
BIOGEN INC. | Health Technology |
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Health Technology |
The United States Army (District of Columbia) | Government |